Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin
- Indications Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ENCORE
- 02 Jun 2015 Five-year follow-up results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 31 Mar 2010 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 31 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.